Literature DB >> 29589499

Teres major tendon transfer in the treatment of irreparable posterosuperior rotator cuff tears: long-term improvement of shoulder function and pain reduction at eight to 12 years’ follow-up.

A Kolk1, J F Henseler1, F J Overes1, J Nagels1, R G H H Nelissen1.   

Abstract

Aims: Since long-term outcome of teres major tendon transfer surgery for irreparable posterosuperior rotator cuff (RC) tears is largely unknown, the primary aim of this study was to evaluate the long-term outcome of the teres major transfer. We also aimed to report on the results of a cohort of patients with a similar indication for surgery that underwent a latissimus dorsi tendon transfer. Patients and
Methods: Patients and Methods In this prospective cohort study, we reported on the long-term results of 20 consecutive patients with a teres major tendon transfer for irreparable massive posterosuperior RC tears. Additionally, we reported on the results of the latissimus dorsi tendon transfer (n = 19). The mean age was 60 years (47 to 77). Outcomes included the Constant score (CS), and pain at rest and during movement using the Visual Analogue Scale (VAS).
Results: At a mean of ten years (8 to 12) following teres major transfer, the CS was still 23 points (95% confidence interval (CI) 14.6 to 30.9, p < 0.001) higher than preoperatively. VAS for pain at rest (21 mm, 95% CI 4.0 to 38.9, p = 0.016) and movement (31 mm, 95% CI 16.0 to 45.1, p < 0.001) were lower than preoperatively. We also found an increase in CS (32 points, 95% CI 23.4 to 40.2, p < 0.001) and reduction of pain (26 mm, 95% CI 9.9 to 41.8, p = 0.001) six years after latissimus dorsi transfer.
Conclusion: Teres major tendon transfer is a treatment option to gain shoulder function and reduce pain in patients with an irreparable posterosuperior RC tear at a mean follow-up of ten years. The teres major tendon might be a valuable alternative to the commonly performed latissimus dorsi tendon transfer in the treatment of irreparable posterosuperior RC tears. Cite this article: Bone Joint J 2018;100-B:309-17.

Entities:  

Keywords:  Massive rotator cuff tear; Pain; Quality of life; Shoulder; Surgery; Tendon transfer

Mesh:

Year:  2018        PMID: 29589499     DOI: 10.1302/0301-620X.100B3.BJJ-2017-0920.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  5 in total

1.  Low level of evidence for all treatment modalities for irreparable posterosuperior rotator cuff tears.

Authors:  Bauke Kooistra; Navin Gurnani; Alexander Weening; Michel van den Bekerom; Derek van Deurzen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-09-18       Impact factor: 4.342

2.  Significant improvement in patient self-assessed comfort and function at six weeks after the smooth and move procedure for shoulders with irreparable rotator cuff tears and retained active elevation.

Authors:  Frederick A Matsen; Anastasia Whitson; Sarah E Jackins; Jason E Hsu
Journal:  Int Orthop       Date:  2019-03-22       Impact factor: 3.075

Review 3.  Nonarthroplasty options for massive, irreparable rotator cuff tears have improvement in range of motion and patient-reported outcomes at short-term follow-up: a systematic review.

Authors:  Jonathan D Hughes; Brian Davis; Emily Whicker; Gregory R Sprowls; Lindsay Barrera; Ashkan Baradaran; Soheil Sabzevari; Jeremy M Burnham; Anup A Shah; Albert Lin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-08-16       Impact factor: 4.114

4.  Tendon transfers for irreparable rotator cuff tears.

Authors:  John R Adam; Shashi K T Nanjayan; Melissa Johnson; Amar Rangan
Journal:  J Clin Orthop Trauma       Date:  2021-04-03

5.  The gelling effect of platelet-rich fibrin matrix when exposed to human tenocytes from the rotator cuff in small-diameter culture wells and the design of a co-culture device to overcome this phenomenon.

Authors:  C-H Chiu; P Chen; W-L Yeh; A C-Y Chen; Y-S Chan; K-Y Hsu; K-F Lei
Journal:  Bone Joint Res       Date:  2019-06-05       Impact factor: 5.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.